Ataxia Magazine 206
SCA research, accessible airlines, raising awareness in Farnham and benefits of a gluten-free diet.
Ataxia Magazine 206 Read More »
Euro-ataxia publishes patient charter outlining mission for patient involvement in ataxia clinical trials
At the Euro-ataxia meeting in Frankfurt on 9th November 2018 a workshop was held to discuss the role of patients and patient groups in research. This led to the creation of the Euro-ataxia patient charter which has now been published.
Cadent Therapeutics aims to begin new trial in SCAs by the end of 2019
Earlier this year the FDA granted an Orphan Drug Designation to an investigational treatment developed by Cadent Therapeutics for spinocerebellar ataxia. They plan to begin a clinical trial by the end of 2019.
Cadent Therapeutics aims to begin new trial in SCAs by the end of 2019 Read More »
The Big Give Christmas Challenge: Ann’s story
Ann tells us about her granddaughter’s challenges accessing care for her ataxia and the lengthy travels the members of the Support Group have to go on.
The Big Give Christmas Challenge: Ann’s story Read More »
The Big Give Christmas Challenge: Ceri’s story
Ceri shares with us how important access to better care would be a dream to her family.
The Big Give Christmas Challenge: Ceri’s story Read More »
The Big Give Christmas Challenge: Gemma’s story
Gemma faces many challenges when travelling to get the card she needs. Read her story here.
The Big Give Christmas Challenge: Gemma’s story Read More »
The Big Give Christmas Challenge: Georgia’s story
Living in North England, Georgia has to travel a long way to access the care she needs for her ataxia.
The Big Give Christmas Challenge: Georgia’s story Read More »
The Big Give Christmas Challenge: Taryn’s Story
This Christmas Taryn tells us how access to appropriate care would benefit her life.
The Big Give Christmas Challenge: Taryn’s Story Read More »
Double your donation, double your impact!
Donate here to double your donations to Ataxia UK at no extra cost to you!
Double your donation, double your impact! Read More »
The International Ataxia Research Conference 2019 in Washington DC was a great success
Ataxia UK representatives attended the 3rd international ataxia research conference, organised by Ataxia UK, FARA, FARA Australia and GoFAR, took place on 14-16 November 2019.
The International Ataxia Research Conference 2019 in Washington DC was a great success Read More »
Depressive symptoms predict quality of life in FA patients and deserve recognition
A recent study has demonstrated depression has a significant impact on the quality of life of patients with Friedreich’s ataxia.
Depressive symptoms predict quality of life in FA patients and deserve recognition Read More »
The UK’s first Ataxia Centre for Children!
Thanks to your generous giving to the Big Give last year, we are ecstatic to announce the first Ataxia Specialist Centre for children.
The UK’s first Ataxia Centre for Children! Read More »
Minoryx Therapeutics granted FDA Orphan Drug Designation in Friedreich’s Ataxia for new drug leriglitazone
Minoryx Therapeutics has announced that its lead drug candidate, leriglitazone (MIN-102), has been given an Orphan Drug Designation for Friedreich’s Ataxia by the US Food and Drug Administration (FDA).
Very exciting results from Friedreich’s ataxia (FA) study
Reata Pharmaceuticals Inc have announced some brilliant news following a study into Friedreich’s ataxia treatment.
Very exciting results from Friedreich’s ataxia (FA) study Read More »
Minoryx Therapeutics completes enrollment in FRAMES phase 2 trial with leriglitazone in Friedreich’s Ataxia
Recruitment of 39 patients in multicenter European
phase 2 trial completed ahead of schedule
Ataxia UK funds new trial investigating non-invasive brain stimulation as a potential therapy for all ataxias
An innovative brain stimulation technique known as ‘transcranial Direct Current Stimulation’ or ‘tCDS’ is being trialled as a potential therapy for all ataxias by an Ataxia UK funded research group in Italy.
Disordered not Drunk: Terry’s story
Terry Wigzell is another person from the ataxia community who has faced prejudice from the police and TfL workers. Read his story here.
Disordered not Drunk: Terry’s story Read More »
Disordered not Drunk: Joe’s Story
After a day in the library trying to help his mum, Joe was accused of being drunk and lying. Find out what happened here.
Disordered not Drunk: Joe’s Story Read More »
Disordered not Drunk: James’ Story
James Moore is Emmerdale’s well-loved actor and recently won the Best Newcomer Award 2019. He shares his story of a time when someone didn’t believe him about his own health condition.
Disordered not Drunk: James’ Story Read More »
Ataxia UK and FARA-funded project into heart disease associated with FA
Dr Carroll and his team have completed a project into a cause of heart disease associated with Friedreich’s ataxia (FA).
Ataxia UK and FARA-funded project into heart disease associated with FA Read More »
Disordered not Drunk: Dinesh’s story
Here, Dinesh tells us about a time when someone wrongly accused him of being drunk, and the detrimental effect it had afterwards.
Disordered not Drunk: Dinesh’s story Read More »
The current state of biomarker research for Friedreich’s ataxia: a recent report from the 2018 FARA biomarker meeting
The US Friedreich’s ataxia charity FARA recently held a Biomarker Meeting reflecting on the current state of the development of these biomarkers.
Levels of the protein Nrf2 affect the development of the brain and spinal cord in Friedreich’s ataxia
A recent study has shown that reduced Nrf2 levels in embryos taken from mice with FA affects the development of the brain and spinal cord.
Disordered not Drunk: Jason’s story
You don’t expect to be judged when using public transport, but for people like Jason, this is what happened. Here’s what happened when Jason was accused of being drunk due to his ataxia.
Disordered not Drunk: Jason’s story Read More »
Disordered not Drunk: Martin’s story
Martin has been stopped driving more than once and accused of being drunk. Here he shares his story.
Disordered not Drunk: Martin’s story Read More »
Completing a half marathon, go Maisie!
Nine year old Maisie and her family were over the moon when she completed the Plymouth half marathon. Here is her mum, Stacey, to tell the fantastic story!
Completing a half marathon, go Maisie! Read More »
Blue badge, Hynt and Live access cards
After their brilliant introduction story a couple of weeks ago, Kizzy and Kathy are back to share some more useful tips with you!
Blue badge, Hynt and Live access cards Read More »
My journey to an ataxia diagnosis
Ataxia is so rare that it can take years for people to receive a correct diagnosis. David shares his journey here.
My journey to an ataxia diagnosis Read More »
Toxic protein production reduced in SCA3 and SCA1 by genetic approach
Spinocerebellar ataxia type 3 (SCA3) and type 1 (SCA1) are caused by mutations in the Ataxin-3 and Ataxin-1 genes that. Researchers recently tested out a type of therapy that works by targeting these genes.
Toxic protein production reduced in SCA3 and SCA1 by genetic approach Read More »
